317 related articles for article (PubMed ID: 33274568)
41. Obstetrical and neonatal outcomes of cardio-facio-cutaneous syndrome: Prenatal consequences of Ras/MAPK dysregulation.
Jelin AC; Mahle A; Tran SH; Sparks TN; Rauen KA
Am J Med Genet A; 2023 Feb; 191(2):323-331. PubMed ID: 36308388
[TBL] [Abstract][Full Text] [Related]
42. Adult mice expressing a Braf Q241R mutation on an ICR/CD-1 background exhibit a cardio-facio-cutaneous syndrome phenotype.
Moriya M; Inoue S; Miyagawa-Tomita S; Nakashima Y; Oba D; Niihori T; Hashi M; Ohnishi H; Kure S; Matsubara Y; Aoki Y
Hum Mol Genet; 2015 Dec; 24(25):7349-60. PubMed ID: 26472072
[TBL] [Abstract][Full Text] [Related]
43. Mutational and functional analysis in human Ras/MAP kinase genetic syndromes.
Tidyman WE; Rauen KA
Methods Mol Biol; 2010; 661():433-47. PubMed ID: 20812000
[TBL] [Abstract][Full Text] [Related]
44. A transient myelodysplastic/myeloproliferative neoplasm in a patient with cardio-facio-cutaneous syndrome and a germline BRAF mutation.
Sekiguchi K; Maeda T; Suenobu S; Kunisaki N; Shimizu M; Kiyota K; Handa YS; Akiyoshi K; Korematsu S; Aoki Y; Matsubara Y; Izumi T
Am J Med Genet A; 2013 Oct; 161A(10):2600-3. PubMed ID: 23950000
[TBL] [Abstract][Full Text] [Related]
45. CNS imaging is a key diagnostic tool in the evaluation of patients with CFC syndrome: two cases and literature review.
Papadopoulou E; Sifakis S; Sol-Church K; Klein-Zighelboim E; Stabley DL; Raissaki M; Gripp KW; Kalmanti M
Am J Med Genet A; 2011 Mar; 155A(3):605-11. PubMed ID: 21337689
[TBL] [Abstract][Full Text] [Related]
46. Cardio-facio-cutaneous syndrome-associated pathogenic MAP2K1 variants activate autophagy.
Chen J; Che L; Xu C; Zhao S; Yang J; Li M; Li G; Shen Y
Gene; 2020 Apr; 733():144369. PubMed ID: 31972311
[TBL] [Abstract][Full Text] [Related]
47. Craniofacial and dental development in Costello syndrome.
Goodwin AF; Oberoi S; Landan M; Charles C; Massie JC; Fairley C; Rauen KA; Klein OD
Am J Med Genet A; 2014 Jun; 164A(6):1425-30. PubMed ID: 24668879
[TBL] [Abstract][Full Text] [Related]
48. Activated Braf induces esophageal dilation and gastric epithelial hyperplasia in mice.
Inoue SI; Takahara S; Yoshikawa T; Niihori T; Yanai K; Matsubara Y; Aoki Y
Hum Mol Genet; 2017 Dec; 26(23):4715-4727. PubMed ID: 28973166
[TBL] [Abstract][Full Text] [Related]
49. Cardio-facio-cutaneous syndrome: clinical features, diagnosis, and management guidelines.
Pierpont ME; Magoulas PL; Adi S; Kavamura MI; Neri G; Noonan J; Pierpont EI; Reinker K; Roberts AE; Shankar S; Sullivan J; Wolford M; Conger B; Santa Cruz M; Rauen KA
Pediatrics; 2014 Oct; 134(4):e1149-62. PubMed ID: 25180280
[TBL] [Abstract][Full Text] [Related]
50. C-type natriuretic peptide improves growth retardation in a mouse model of cardio-facio-cutaneous syndrome.
Inoue SI; Morozumi N; Yoshikiyo K; Maeda H; Aoki Y
Hum Mol Genet; 2019 Jan; 28(1):74-83. PubMed ID: 30239744
[TBL] [Abstract][Full Text] [Related]
51. Integrating Functional Analysis in the Next-Generation Sequencing Diagnostic Pipeline of RASopathies.
Leung GKC; Luk HM; Tang VHM; Gao WW; Mak CCY; Yu MHC; Wong WL; Chu YWY; Yang WL; Wong WHS; Ma ACH; Leung AYH; Jin DY; Chan KYK; Allanson J; Lo IFM; Chung BHY
Sci Rep; 2018 Feb; 8(1):2421. PubMed ID: 29402968
[TBL] [Abstract][Full Text] [Related]
52. Two novel germline KRAS mutations: expanding the molecular and clinical phenotype.
Stark Z; Gillessen-Kaesbach G; Ryan MM; Cirstea IC; Gremer L; Ahmadian MR; Savarirayan R; Zenker M
Clin Genet; 2012 Jun; 81(6):590-4. PubMed ID: 21797849
[TBL] [Abstract][Full Text] [Related]
53. MAP2K2 mutation as a cause of cardio-facio-cutaneous syndrome in an infant with a severe and fatal course of the disease.
Gos M; Smigiel R; Kaczan T; Landowska A; Abramowicz A; Sasiadek M; Bal J
Am J Med Genet A; 2018 Jul; 176(7):1670-1674. PubMed ID: 29799162
[TBL] [Abstract][Full Text] [Related]
54. Status epilepticus in BRAF-related cardio-facio-cutaneous syndrome: Focus on neuroimaging clues to physiopathology.
Musto E; Gambardella ML; Perulli M; Quintiliani M; Veredice C; Verdolotti T; Berté G; Leoni C; Onesimo R; Pulitanò SM; Tartaglia M; Zampino G; Contaldo I; Battaglia DI
Epilepsia Open; 2024 Feb; 9(1):258-267. PubMed ID: 37943120
[TBL] [Abstract][Full Text] [Related]
55. Cardio-facio-cutaneous syndrome: phenotypic variability and differential diagnosis in 3 cases with de novo BRAF mutations.
Demir E; Mancano G; Pomponi MG; Ozcelik A; Gucuyener K; Neri G
Neuropediatrics; 2010 Jun; 41(3):127-31. PubMed ID: 20859831
[TBL] [Abstract][Full Text] [Related]
56. Activating mutations in BRAF disrupt the hypothalamo-pituitary axis leading to hypopituitarism in mice and humans.
Gualtieri A; Kyprianou N; Gregory LC; Vignola ML; Nicholson JG; Tan R; Inoue SI; Scagliotti V; Casado P; Blackburn J; Abollo-Jimenez F; Marinelli E; Besser REJ; Högler W; Karen Temple I; Davies JH; Gagunashvili A; Robinson ICAF; Camper SA; Davis SW; Cutillas PR; Gevers EF; Aoki Y; Dattani MT; Gaston-Massuet C
Nat Commun; 2021 Apr; 12(1):2028. PubMed ID: 33795686
[TBL] [Abstract][Full Text] [Related]
57. Continual low-level MEK inhibition ameliorates cardio-facio-cutaneous phenotypes in zebrafish.
Anastasaki C; Rauen KA; Patton EE
Dis Model Mech; 2012 Jul; 5(4):546-52. PubMed ID: 22301711
[TBL] [Abstract][Full Text] [Related]
58. Germline mutations of MEK in cardio-facio-cutaneous syndrome are sensitive to MEK and RAF inhibition: implications for therapeutic options.
Senawong T; Phuchareon J; Ohara O; McCormick F; Rauen KA; Tetsu O
Hum Mol Genet; 2008 Feb; 17(3):419-30. PubMed ID: 17981815
[TBL] [Abstract][Full Text] [Related]
59. Noonan, Costello and cardio-facio-cutaneous syndromes: dysregulation of the Ras-MAPK pathway.
Tidyman WE; Rauen KA
Expert Rev Mol Med; 2008 Dec; 10():e37. PubMed ID: 19063751
[TBL] [Abstract][Full Text] [Related]
60. Alterations in RAS-MAPK genes in 200 Spanish patients with Noonan and other neuro-cardio-facio-cutaneous syndromes. Genotype and cardiopathy.
Ezquieta B; Santomé JL; Carcavilla A; Guillén-Navarro E; Pérez-Aytés A; Sánchez del Pozo J; García-Miñaur S; Castillo E; Alonso M; Vendrell T; Santana A; Maroto E; Galbis L
Rev Esp Cardiol (Engl Ed); 2012 May; 65(5):447-55. PubMed ID: 22465605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]